{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:35:53Z","timestamp":1791909353590,"version":"4.3.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T00:00:00Z","timestamp":1532476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council (NHMRC)","doi-asserted-by":"publisher","award":["APP1065314"],"award-info":[{"award-number":["APP1065314"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council (NHMRC)","doi-asserted-by":"publisher","award":["APP1065314"],"award-info":[{"award-number":["APP1065314"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council (NHMRC)","doi-asserted-by":"publisher","award":["APP1065314"],"award-info":[{"award-number":["APP1065314"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council (NHMRC)","doi-asserted-by":"publisher","award":["APP1065314"],"award-info":[{"award-number":["APP1065314"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council (NHMRC)","doi-asserted-by":"publisher","award":["APP1065314"],"award-info":[{"award-number":["APP1065314"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council (NHMRC)","doi-asserted-by":"publisher","award":["APP1065314"],"award-info":[{"award-number":["APP1065314"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council (NHMRC)","doi-asserted-by":"publisher","award":["APP1065314"],"award-info":[{"award-number":["APP1065314"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council (NHMRC)","doi-asserted-by":"publisher","award":["APP1065314"],"award-info":[{"award-number":["APP1065314"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1038\/s41375-018-0206-x","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T13:31:37Z","timestamp":1532525497000},"page":"457-468","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["Subclonal evolution in disease progression from MGUS\/SMM to multiple myeloma is characterised by clonal stability"],"prefix":"10.1038","volume":"33","author":[{"given":"Ankit K.","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Lynn","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth J.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1871-1850","authenticated-orcid":false,"given":"Charles G.","family":"Mullighan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luen B.","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan R.","family":"Hewett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6646-6167","authenticated-orcid":false,"given":"Andrew C. W.","family":"Zannettino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,25]]},"reference":[{"key":"206_CR1","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ajh.24402","volume":"91","author":"SV Rajkumar","year":"2016","unstructured":"Rajkumar SV. Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol. 2016;91:719\u201334.","journal-title":"Am J Hematol"},{"key":"206_CR2","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/leu.2013.313","volume":"28","author":"SK Kumar","year":"2014","unstructured":"Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, et al.\u00a0Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2014;28:1122\u20138.","journal-title":"Leukemia"},{"key":"206_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/bjh.14304","volume":"175","author":"D Smith","year":"2016","unstructured":"Smith D, Yong K. Advances in understanding prognosis in myeloma. Br J Haematol. 2016;175:367\u201380.","journal-title":"Br J Haematol"},{"key":"206_CR4","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/leu.2013.199","volume":"28","author":"BA Walker","year":"2014","unstructured":"Walker BA, Wardell CP, Melchor L, Brioli A, Johnson DC, Kaiser MF,\u00a0et al. Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms. Leukemia. 2014;28:384\u201390.","journal-title":"Leukemia"},{"key":"206_CR5","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJMra1011442","volume":"364","author":"A Palumbo","year":"2011","unstructured":"Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364:1046\u201360.","journal-title":"N Engl J Med"},{"key":"206_CR6","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB,\u00a0et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009;113:5412\u20137.","journal-title":"Blood"},{"key":"206_CR7","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1056\/NEJMoa01133202","volume":"346","author":"RA Kyle","year":"2002","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF,\u00a0et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346:564\u20139.","journal-title":"N Engl J Med"},{"key":"206_CR8","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1056\/NEJMoa070389","volume":"356","author":"RA Kyle","year":"2007","unstructured":"Kyle RA, Remstein ED, Therneau TM, Dispenzieri A, Kurtin PJ, Hodnefield JM,\u00a0et al. Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med. 2007;356:2582\u201390.","journal-title":"N Engl J Med"},{"key":"206_CR9","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood.V100.4.1417.h81602001417_1417_1424","volume":"100","author":"R Fonseca","year":"2002","unstructured":"Fonseca R, Bailey RJ, Ahmann GJ, Rajkumar SV, Hoyer JD, Lust JA,\u00a0et al. Genomic abnormalities in monoclonal gammopathy of undetermined significance. Blood. 2002;100:1417\u201324.","journal-title":"Blood"},{"key":"206_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature09837","volume":"471","author":"MA Chapman","year":"2011","unstructured":"Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, Schinzel AC,\u00a0et al. Initial genome sequencing and analysis of multiple myeloma. Nature. 2011;471:467\u201372.","journal-title":"Nature"},{"key":"206_CR11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrc.2017.63","volume":"17","author":"C Pawlyn","year":"2017","unstructured":"Pawlyn C, Morgan GJ. Evolutionary biology of high-risk multiple myeloma. Nat Rev Cancer. 2017;17:543\u201356.","journal-title":"Nat Rev Cancer"},{"key":"206_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/bjh.14649","volume":"178","author":"AK Dutta","year":"2017","unstructured":"Dutta AK, Hewett DR, Fink JL, Grady JP, Zannettino ACW. Cutting edge genomics reveal new insights into tumour development, disease progression and therapeutic impacts in multiple myeloma. Br J Haematol. 2017;178:196\u2013208.","journal-title":"Br J Haematol"},{"key":"206_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nrclinonc.2016.122","volume":"14","author":"S Manier","year":"2017","unstructured":"Manier S, Salem KZ, Park J, Landau DA, Getz G, Ghobrial IM. Genomic complexity of multiple myeloma and its clinical implications. Nat Rev Clin Oncol. 2017;14:100\u201313.","journal-title":"Nat Rev Clin Oncol"},{"key":"206_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.gde.2015.03.008","volume":"30","author":"R Szalat","year":"2015","unstructured":"Szalat R, Munshi NC. Genomic heterogeneity in multiple myeloma. Curr Opin Genet Dev. 2015;30:56\u201365.","journal-title":"Curr Opin Genet Dev"},{"key":"206_CR15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/bjh.12805","volume":"165","author":"A Brioli","year":"2014","unstructured":"Brioli A, Melchor L, Cavo M, Morgan GJ. The impact of intra-clonal heterogeneity on the treatment of multiple myeloma. Br J Haematol. 2014;165:441\u201354.","journal-title":"Br J Haematol"},{"key":"206_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nature10762","volume":"481","author":"M Greaves","year":"2012","unstructured":"Greaves M, Maley CC. Clonal evolution in cancer. Nature. 2012;481:306\u201313.","journal-title":"Nature"},{"key":"206_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrc3257","volume":"12","author":"GJ Morgan","year":"2012","unstructured":"Morgan GJ, Walker BA, Davies FE. The genetic architecture of multiple myeloma. Nat Rev Cancer. 2012;12:335\u201348.","journal-title":"Nat Rev Cancer"},{"key":"206_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3997","volume":"5","author":"N Bolli","year":"2014","unstructured":"Bolli N, Avet-Loiseau H, Wedge DC, Van Loo P, Alexandrov LB, Martincorena I,\u00a0et al. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat Commun. 2014;5:2997.","journal-title":"Nat Commun"},{"key":"206_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccr.2013.12.015","volume":"25","author":"JG Lohr","year":"2014","unstructured":"Lohr JG, Stojanov P, Carter SL, Cruz-Gordillo P, Lawrence MS, Auclair D,\u00a0et al. Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy. Cancer Cell. 2014;25:91\u2013101.","journal-title":"Cancer Cell"},{"key":"206_CR20","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1200\/JCO.2014.59.1503","volume":"33","author":"BA Walker","year":"2015","unstructured":"Walker BA, Boyle EM, Wardell CP, Murison A, Begum DB, Dahir NM,\u00a0et al. Mutational spectrum, copy number changes, and outcome: results of a sequencing study of patients with newly diagnosed myeloma. J Clin Oncol. 2015;33:3911\u201320.","journal-title":"J Clin Oncol"},{"key":"206_CR21","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.1158\/0008-5472.CAN-17-0115","volume":"77","author":"K Vandyke","year":"2017","unstructured":"Vandyke K, Zeissig MN, Hewett DR, Martin SK, Mrozik KM, Cheong CM,\u00a0et al. HIF-2alpha promotes dissemination of plasma cells in multiple myeloma by regulating CXCL12\/CXCR4 and CCR1. Cancer Res. 2017;77:5452\u201363.","journal-title":"Cancer Res"},{"key":"206_CR22","first-page":"11","volume":"43","author":"GA Auwera Van der","year":"2013","unstructured":"Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy-Moonshine A,\u00a0et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics 2013;43:11\u201333. 11 10","journal-title":"Curr Protoc Bioinforma"},{"key":"206_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C,\u00a0et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31:213\u20139.","journal-title":"Nat Biotechnol"},{"key":"206_CR24","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/nar\/gkv135","volume":"43","author":"M Josephidou","year":"2015","unstructured":"Josephidou M, Lynch AG, Tavare S. multiSNV: a probabilistic approach for improving detection of somatic point mutations from multiple related tumour samples. Nucleic Acids Res. 2015;43:e61.","journal-title":"Nucleic Acids Res"},{"key":"206_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani P, Platts A, Wang le L, Coon M, Nguyen T, Wang L,\u00a0et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strainw1118; iso-2; iso-3. Fly. 2012;6:80\u201392.","journal-title":"Fly (Austin)"},{"key":"206_CR26","doi-asserted-by":"publisher","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","volume":"12","author":"E Talevich","year":"2016","unstructured":"Talevich E, Shain AH, Botton T, Bastian BC. CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput Biol. 2016;12:e1004873.","journal-title":"PLoS Comput Biol"},{"key":"206_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0602-8","volume":"16","author":"AG Deshwar","year":"2015","unstructured":"Deshwar AG, Vembu S, Yung CK, Jang GH, Stein L, Morris Q. PhyloWGS: reconstructing subclonal composition and evolution from whole-genome sequencing of tumors. Genome Biol. 2015;16:35.","journal-title":"Genome Biol"},{"key":"206_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-016-3195-z","volume":"17","author":"CA Miller","year":"2016","unstructured":"Miller CA, McMichael J, Dang HX, Maher CA, Ding L, Ley TJ,\u00a0et al. Visualizing tumor evolution with the fishplot package for R. BMC Genomics 2016;17:880.","journal-title":"BMC Genom"},{"key":"206_CR29","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1182\/blood-2012-01-405977","volume":"120","author":"JB Egan","year":"2012","unstructured":"Egan JB, Shi CX, Tembe W, Christoforides A, Kurdoglu A, Sinari S,\u00a0et al. Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides. Blood. 2012;120:1060\u20136.","journal-title":"Blood"},{"key":"206_CR30","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1182\/blood-2012-03-412981","volume":"120","author":"BA Walker","year":"2012","unstructured":"Walker BA, Wardell CP, Melchor L, Hulkki S, Potter NE, Johnson DC,\u00a0et al. Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma. Blood. 2012;120:1077\u201386.","journal-title":"Blood"},{"key":"206_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/bjh.13256","volume":"169","author":"S Weissbach","year":"2015","unstructured":"Weissbach S, Langer C, Puppe B, Nedeva T, Bach E, Kull M,\u00a0et al. The molecular spectrum and clinical impact of DIS3 mutations in multiple myeloma. Br J Haematol. 2015;169:57\u201370.","journal-title":"Br J Haematol"},{"key":"206_CR32","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1038\/leu.2012.128","volume":"26","author":"L Lopez-Corral","year":"2012","unstructured":"Lopez-Corral L, Sarasquete ME, Bea S, Garcia-Sanz R, Mateos MV, Corchete LA,\u00a0et al. SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status. Leukemia. 2012;26:2521\u20139.","journal-title":"Leukemia"},{"issue":"9","key":"206_CR33","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3324\/haematol.2017.163766","volume":"102","author":"Aneta Mikulasova","year":"2017","unstructured":"Mikulasova A, Wardell CP, Murison A, Boyle EM, Jackson GH, Smetana J,\u00a0et al. Somatic mutation spectrum in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape compared to multiple myeloma. Haematologica. 2017;102:1617\u201325.","journal-title":"Haematologica"},{"key":"206_CR34","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/leu.2014.59","volume":"28","author":"S Zhao","year":"2014","unstructured":"Zhao S, Choi M, Heuck C, Mane S, Barlogie B, Lifton RP,\u00a0et al. Serial exome analysis of disease progression in premalignant gammopathies. Leukemia. 2014;28:1548\u201352.","journal-title":"Leukemia"},{"key":"206_CR35","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/leu.2014.13","volume":"28","author":"L Melchor","year":"2014","unstructured":"Melchor L, Brioli A, Wardell CP, Murison A, Potter NE, Kaiser MF,\u00a0et al. Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma. Leukemia. 2014;28:1705\u201315.","journal-title":"Leukemia"},{"key":"206_CR36","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","volume":"168","author":"N McGranahan","year":"2017","unstructured":"McGranahan N, Swanton C. Clonal heterogeneity and tumor evolution: past, present, and the future. Cell. 2017;168:613\u201328.","journal-title":"Cell"},{"key":"206_CR37","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1158\/1078-0432.CCR-10-1066","volume":"17","author":"L Lopez-Corral","year":"2011","unstructured":"Lopez-Corral L, Gutierrez NC, Vidriales MB, Mateos MV, Rasillo A, Garcia-Sanz R,\u00a0et al. The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells. Clin Cancer Res. 2011;17:1692\u20131700.","journal-title":"Clin Cancer Res"},{"key":"206_CR38","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1182\/blood-2012-01-405985","volume":"120","author":"JJ Keats","year":"2012","unstructured":"Keats JJ, Chesi M, Egan JB, Garbitt VM, Palmer SE, Braggio E,\u00a0et al. Clonal competition with alternating dominance in multiple myeloma. Blood. 2012;120:1067\u201376.","journal-title":"Blood"},{"key":"206_CR39","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/leu.2012.226","volume":"27","author":"F Magrangeas","year":"2013","unstructured":"Magrangeas F, Avet-Loiseau H, Gouraud W, Lode L, Decaux O, Godmer P,\u00a0et al. Minor clone provides a reservoir for relapse in multiple myeloma. Leukemia. 2013;27:473\u201381.","journal-title":"Leukemia"},{"key":"206_CR40","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00277-015-2344-9","volume":"94","author":"KM Kortum","year":"2015","unstructured":"Kortum KM, Langer C, Monge J, Bruins L, Zhu YX, Shi CX,\u00a0et al. Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P). Ann Hematol. 2015;94:1205\u201311.","journal-title":"Ann Hematol"},{"key":"206_CR41","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/leu.2012.287","volume":"27","author":"N Weston-Bell","year":"2013","unstructured":"Weston-Bell N, Gibson J, John M, Ennis S, Pfeifer S, Cezard T,\u00a0et al. Exome sequencing in tracking clonal evolution in multiple myeloma following therapy. Leukemia. 2013;27:1188\u201391.","journal-title":"Leukemia"},{"key":"206_CR42","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1182\/blood-2016-09-692954","volume":"128","author":"MV Dhodapkar","year":"2016","unstructured":"Dhodapkar MV. MGUS to myeloma: a mysterious gammopathy of underexplored significance. Blood. 2016;128:2599\u2013606.","journal-title":"Blood"},{"issue":"4","key":"206_CR43","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrclinonc.2017.197","volume":"15","author":"Irene M. Ghobrial","year":"2018","unstructured":"Ghobrial IM, Detappe A, Anderson KC, Steensma DP. The bone-marrow niche in MDS and MGUS: implications for AML and MM. Nat Rev Clin Oncol. 2018;15:219\u201333.","journal-title":"Nature Reviews Clinical Oncology"},{"key":"206_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2012.38","volume":"2","author":"JE Noll","year":"2012","unstructured":"Noll JE, Williams SA, Purton LE, Zannettino AC. Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche? Blood Cancer J. 2012;2:e91.","journal-title":"Blood Cancer J"},{"key":"206_CR45","doi-asserted-by":"publisher","first-page":"157496","DOI":"10.1155\/2012\/157496","volume":"2012","author":"S Manier","year":"2012","unstructured":"Manier S, Sacco A, Leleu X, Ghobrial IM, Roccaro AM. Bone marrow microenvironment in multiple myeloma progression. J Biomed Biotechnol. 2012;2012:157496.","journal-title":"J Biomed Biotechnol"},{"key":"206_CR46","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.neo.2017.09.004","volume":"19","author":"DR Hewett","year":"2017","unstructured":"Hewett DR, Vandyke K, Lawrence DM, Friend N, Noll JE, Geoghegan JM,\u00a0et al. DNA barcoding reveals habitual clonal dominance of myeloma plasma cells in the bone marrow microenvironment. Neoplasia. 2017;19:972\u201381.","journal-title":"Neoplasia"},{"key":"206_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9983","volume":"6","author":"MA Lawson","year":"2015","unstructured":"Lawson MA, McDonald MM, Kovacic N, Hua Khoo W, Terry RL, Down J,\u00a0et al. Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche. Nat Commun. 2015;6:8983.","journal-title":"Nat Commun"},{"key":"206_CR48","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/nm.4202","volume":"22","author":"R Das","year":"2016","unstructured":"Das R, Strowig T, Verma R, Koduru S, Hafemann A, Hopf S,\u00a0et al. Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice. Nat Med. 2016;22:1351\u20137.","journal-title":"Nat Med"},{"key":"206_CR49","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.ejca.2005.12.025","volume":"42","author":"CS Mitsiades","year":"2006","unstructured":"Mitsiades CS, Mitsiades NS, Munshi NC, Richardson PG, Anderson KC. The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: interplay of growth factors, their receptors and stromal interactions. Eur J Cancer. 2006;42:1564\u201373.","journal-title":"Eur J Cancer"},{"key":"206_CR50","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1182\/blood-2014-07-552059","volume":"124","author":"B Barlogie","year":"2014","unstructured":"Barlogie B, Mitchell A, van Rhee F, Epstein J, Morgan GJ, Crowley J. Curing myeloma at last: defining criteria and providing the evidence. Blood. 2014;124:3043\u201351.","journal-title":"Blood"},{"key":"206_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00296-y","volume":"8","author":"L Rasche","year":"2017","unstructured":"Rasche L, Chavan SS, Stephens OW, Patel PH, Tytarenko R, Ashby C,\u00a0et al. Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing. Nat Commun. 2017;8:268.","journal-title":"Nat Commun"},{"key":"206_CR52","doi-asserted-by":"publisher","first-page":"548","DOI":"10.14694\/EDBK_175175","volume":"37","author":"M Bustoros","year":"2017","unstructured":"Bustoros M, Mouhieddine TH, Detappe A, Ghobrial IM. Established and novel prognostic biomarkers in multiple myeloma. Am Soc Clin Oncol Educ Book. 2017;37:548\u201360.","journal-title":"Am Soc Clin Oncol Educ Book"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0206-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0206-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0206-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:35:28Z","timestamp":1684618528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-018-0206-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,25]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["206"],"URL":"https:\/\/doi.org\/10.1038\/s41375-018-0206-x","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,25]]},"assertion":[{"value":"17 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}